1. An Autotaxin/Lysophosphatidic Acid/Interleukin‐6 Amplification Loop Drives Scleroderma Fibrosis. Issue 12 (December 2016) Authors: Castelino, Flavia V.; Bain, Gretchen; Pace, Veronica A.; Black, Katharine E.; George, Leaya; Probst, Clemens K.; Goulet, Lance; Lafyatis, Robert; Tager, Andrew M. Journal: Arthritis & rheumatology Issue: Volume 68:Issue 12(2016) Page Start: 2964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. Issue 6 (22nd March 2016) Authors: Black, Katharine E.; Berdyshev, Evgeny; Bain, Gretchen; Castelino, Flavia V.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Bronova, Irina; Goulet, Lance; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Natarajan, Viswanathan; Tager, Andrew M. Journal: FASEB journal Issue: Volume 30:Issue 6(2016) Page Start: 2435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti‐inflammatory 5‐lipoxygenase‐activating protein inhibitor. (5th February 2013) Authors: Bain, Gretchen; King, Christopher D.; Schaab, Kevin; Rewolinski, Melissa; Norris, Virginia; Ambery, Claire; Bentley, Jane; Yamada, Masanori; Santini, Angelina M.; van de Wetering de Rooij, Jeroen; Stock, Nicholas; Zunic, Jasmine; Hutchinson, John H.; Evans, Jilly F. Journal: British journal of clinical pharmacology Issue: Volume 75:Number 3(2013:Mar.) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗